{"id":"https://openalex.org/W1972175299","doi":"https://doi.org/10.2147/dmso.s49592","title":"Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence","display_name":"Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W1972175299","doi":"https://doi.org/10.2147/dmso.s49592","mag":"1972175299","pmid":"https://pubmed.ncbi.nlm.nih.gov/25926748","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4403747"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s49592","doi":"https://doi.org/10.2147/dmso.s49592","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s49592","pdf_url":"https://www.dovepress.com/getfile.php?fileID=24645","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=24645","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081657937","display_name":"Aravind Sosale","orcid":"https://orcid.org/0000-0001-7631-8777","observed_orcids":["https://orcid.org/0000-0001-7631-8777"]},"institutions":[{"id":"https://openalex.org/I4210111528","display_name":"Diacon Hospital","ror":"https://ror.org/01vst1n89","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210111528"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sosale Aravind Sosale","raw_affiliation_strings":["Diacon Hospital, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diacon Hospital, Bangalore, India","institution_ids":["https://openalex.org/I4210111528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039062359","display_name":"Banshi Saboo","orcid":"https://orcid.org/0000-0001-7293-8864","observed_orcids":["https://orcid.org/0000-0001-7293-8864"]},"institutions":[{"id":"https://openalex.org/I4210131238","display_name":"Diabetes Care & Hormone Clinic","ror":"https://ror.org/02jg1vm67","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210131238"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Banshi Saboo","raw_affiliation_strings":["Dia Care (Diabetes Care and Hormone Clinic), Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dia Care (Diabetes Care and Hormone Clinic), Ahmedabad, India","institution_ids":["https://openalex.org/I4210131238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008172167","display_name":"Bhavana Sosale","orcid":"https://orcid.org/0000-0002-3658-1252","observed_orcids":["https://orcid.org/0000-0002-3658-1252"]},"institutions":[{"id":"https://openalex.org/I4210111528","display_name":"Diacon Hospital","ror":"https://ror.org/01vst1n89","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210111528"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Bhavana Sosale","raw_affiliation_strings":["Diacon Hospital, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diacon Hospital, Bangalore, India","institution_ids":["https://openalex.org/I4210111528"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.2705,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.77547867,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"8","issue":null,"first_page":"189","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.47290000319480896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.47290000319480896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.05829999968409538,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saroglitazar","display_name":"saroglitazar","score":1.0},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ppar-alpha-gamma-agonist","display_name":"PPAR alpha/gamma agonist","score":0.9760000109672546},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.8410000205039978},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.6690000295639038},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7480000257492065},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.699999988079071},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7369999885559082},{"id":"https://openalex.org/keywords/high-density-lipoprotein","display_name":"high-density lipoprotein","score":0.8479999899864197},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6822148561477661},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.6521840691566467},{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.621943473815918},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.6097418069839478},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5588022470474243},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5304096341133118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47791561484336853},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4699523448944092},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4403378963470459},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.4266544580459595},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3951084315776825},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3696305751800537},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3057937026023865},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.12948760390281677},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10274851322174072}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/dmso.s49592","doi":"https://doi.org/10.2147/dmso.s49592","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s49592","pdf_url":"https://www.dovepress.com/getfile.php?fileID=24645","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"pmid:25926748","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25926748","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4403747","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4403747/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.813.7092","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.813.7092","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/ca/06/dmso-8-189.PMC4403747.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:3e5896703be74761849e4f025211a96c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3e5896703be74761849e4f025211a96c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol 2015, Iss default, Pp 189-196 (2015)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/21348","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/saroglitazar-for-the-treatment-of-hypertriglyceridemia-in-patients-wit-peer-reviewed-article-DMSO","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/dmso.s49592","doi":"https://doi.org/10.2147/dmso.s49592","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s49592","pdf_url":"https://www.dovepress.com/getfile.php?fileID=24645","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1972175299.pdf","grobid_xml":"https://content.openalex.org/works/W1972175299.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W180481652","https://openalex.org/W1502524639","https://openalex.org/W1972661406","https://openalex.org/W1973237182","https://openalex.org/W1975018096","https://openalex.org/W1982246196","https://openalex.org/W1996715170","https://openalex.org/W1998675312","https://openalex.org/W2005230906","https://openalex.org/W2038120135","https://openalex.org/W2051922899","https://openalex.org/W2062551263","https://openalex.org/W2089286420","https://openalex.org/W2106051125","https://openalex.org/W2107295258","https://openalex.org/W2121145204","https://openalex.org/W2125871101","https://openalex.org/W2127161077","https://openalex.org/W2142347023","https://openalex.org/W2144251666","https://openalex.org/W2144516660","https://openalex.org/W2144829836","https://openalex.org/W2164324917","https://openalex.org/W2165605025","https://openalex.org/W2410405995","https://openalex.org/W2477872031","https://openalex.org/W2885887894","https://openalex.org/W4230870013","https://openalex.org/W4243530577","https://openalex.org/W7075611726"],"related_works":["https://openalex.org/W2804218549","https://openalex.org/W2082761367","https://openalex.org/W2122725589","https://openalex.org/W2040573695","https://openalex.org/W7115168306","https://openalex.org/W2910782021","https://openalex.org/W4293073877","https://openalex.org/W4402320003","https://openalex.org/W1973237182","https://openalex.org/W2950722971"],"abstract_inverted_index":{"Diabetes":[0],"mellitus":[1],"(DM)":[2],"is":[3,16,37,49,125,147,250],"one":[4],"of":[5,20,31,43,67,77,113,122,135,141,162,175,184,207,238,246,277,292],"the":[6,12,17,64,142,160,173,181,212,219,243,271,290],"most":[7],"dreaded":[8],"metabolic":[9],"disorders":[10],"in":[11,29,71,94,102,129,172,189,228,255,289],"world":[13],"today.":[14],"It":[15],"leading":[18],"cause":[19,66],"morbidity":[21,70],"and":[22,24,33,45,69,83,106,223,231,265],"mortality,":[23],"plays":[25],"a":[26,40,50,85,138,148,197,286],"cardinal":[27],"role":[28,161],"quality":[30],"life":[32],"health":[34],"economics.":[35],"DM":[36,48,78],"associated":[38],"with":[39,73,104,131,191,263,281],"high":[41],"prevalence":[42],"microvascular":[44],"macrovascular":[46],"complications.":[47,154],"very":[51],"important":[52],"cardiovascular":[53],"(CV)":[54],"risk":[55,91,112,144,194],"factor.":[56],"Cardiovascular":[57],"disease":[58],"(CVD)":[59],"has":[60],"been":[61,203],"implicated":[62],"as":[63],"prime":[65],"mortality":[68],"patients":[72,103,130,190],"DM.":[74,132],"Hence,":[75],"treatment":[76],"goes":[79],"beyond":[80],"glycemic":[81,240,258],"control,":[82,241,259],"demands":[84],"multidisciplinary":[86],"approach":[87],"that":[88,221],"comprehensively":[89],"targets":[90],"factors":[92],"inherent":[93],"CV":[95,193],"events.":[96],"Lipid":[97],"abnormalities":[98],"are":[99,179],"undoubtedly":[100],"common":[101],"DM,":[105],"they":[107],"contribute":[108],"to":[109,127,151,205,218],"an":[110,251,266],"increased":[111],"CVD.":[114],"A":[115],"high-risk":[116],"lipid":[117],"profile,":[118],"termed":[119],"atherogenic":[120],"dyslipidemia":[121,187],"diabetes":[123],"(ADD),":[124],"known":[126],"occur":[128],"The":[133,235],"use":[134],"lipid-lowering":[136],"agents,":[137],"quintessential":[139],"part":[140],"multifactorial":[143],"factor":[145],"approach,":[146],"crucial":[149],"intervention":[150],"minimize":[152],"diabetes-related":[153],"In":[155],"this":[156,275],"article,":[157],"we":[158],"discuss":[159],"peroxisome":[163],"proliferator":[164],"activator":[165],"receptor":[166],"(PPAR)":[167],"alpha/gamma":[168],"(\u03b1/\u03b3)":[169],"agonist,":[170],"saroglitazar,":[171],"management":[174,188,291],"ADD.":[176],"While":[177],"statins":[178],"irrefutably":[180],"first":[182],"line":[183],"drugs":[185],"for":[186],"residual":[192],"while":[195],"on":[196,273],"statin,":[198],"PPAR":[199,247,278],"\u03b1/\u03b3":[200,279],"agonists":[201],"have":[202,225],"found":[204],"be":[206],"substantial":[208],"benefit.":[209],"Data":[210],"from":[211],"PRESS":[213],"I-VI":[214],"clinical":[215],"trials":[216],"testify":[217],"fact":[220],"saroglitazar":[222],"fibrates":[224],"similar":[226],"efficacy":[227,260],"reducing":[229],"triglycerides":[230],"improving":[232],"high-density":[233],"lipoprotein.":[234],"ancillary":[236],"benefit":[237],"improved":[239,257],"without":[242],"weight":[244],"gain":[245],"\u03b3":[248],"agonists,":[249,280],"added":[252],"advantage.":[253],"Reduction":[254],"ADD,":[256],"at":[261],"par":[262],"fibrates,":[264],"acceptable":[267],"safety":[268],"profile":[269],"form":[270],"grounds":[272],"which":[274],"group":[276],"their":[282],"novel":[283],"mechanism,":[284],"holds":[285],"promising":[287],"future":[288],"diabetic":[293],"dyslipidemia.":[294]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}